ATLANTA -- The Centers for Disease Control and Prevention (CDC) today took the precautionary step of adding a temporary medical deferral to the smallpox vaccination program for persons who have been diagnosed with heart disease. The CDC is investigating whether there is any association between smallpox vaccination and reports of heart problems in seven healthcare workers who have been vaccinated.
CDC added the temporary measure to the existing list of deferral criteria based on information from its real-time monitoring system, which showed a small number of heart-related incidents among health care workers following smallpox vaccination. It is not clear whether this number is greater than would be expected normally in this population, CDC scientists said.
"We promised to closely monitor this program and to put safety first, so we are exercising exceptional caution," said Julie Gerberding, MD, CDC director. "If our investigation shows this precautionary measure should become permanent or the need for other changes or enhancements in the civilian smallpox vaccination program, we will take immediate action. We continue to believe that it is important and necessary to vaccinate health care workers to prepare our nation in the event we have to respond to a smallpox outbreak," Gerberding said.
CDC is recommending that persons with known cardiac disease -- such as cardiomyopathy, previous heart attack, history of angina, or other evidence of coronary artery disease -- be temporarily deferred from receiving smallpox vaccination. CDC will provide states with simple questions about heart problems to use in screening people volunteering for smallpox vaccination.
In pursuing its promise of safety, last week CDC asked the Advisory Committee on Immunization Practices' (ACIP) Smallpox Vaccine Safety Review Board to examine reports of heart-related adverse events occurring in connection with the smallpox vaccination program. CDC is also beginning research projects aimed at identifying and understanding any associations that may exist between smallpox vaccine and heart-related problems.
"A major part of our monitoring program involves regularly sharing information about adverse events with experts such as those on the ACIP. They can help assess whether the smallpox vaccine is, indeed, associated with the medical conditions described in the adverse event reports," said Walter Orenstein, MD, director of CDC's National Immunization Program.
CDC has received several reports of heart-related problems among the 25,645 people who have been vaccinated in the civilian program. The seven cases prompting today's precautionary action include three cases of myocardial infarction (heart attack), one of which resulted in death; two cases of angina (chest pain); and two cases of myopericarditis (inflammation of the heart muscle or sac surrounding the heart). In each case the individual's medical history, including risk factors for heart disease, is being studied.
Cases of heart inflammation following smallpox vaccination were reported in the 1960s and 1970s. However, the information from these reports does not provide any information about the types of people who may be at higher risk for heart-related problems following smallpox vaccination.
Source: CDC
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.